Biological activity of interleukin-2 bound to Candida albicans

C B Treseler1, R T Maziarz, S M Levitz

  • 1Evans Memorial Department of Clinical Research, Boston University Medical Center, Massachusetts 02118.

Infection and Immunity
|January 1, 1992
PubMed

Insights

Interleukin-2 (IL-2) binds to Candida albicans, a fungus. This interaction enhances the immune response to fungal infections, suggesting a new therapeutic approach for candidiasis.

Area of Science:

  • Immunology
  • Mycology
  • Biochemistry

Background:

  • Interleukin-2 (IL-2) is crucial for cell-mediated immunity.
  • IL-2 exhibits lectin-like properties, binding to mannose-rich structures.
  • Candida albicans is a common fungal pathogen with a mannose-rich cell wall.

Purpose of the Study:

  • To investigate the binding of IL-2 to Candida albicans.
  • To determine if IL-2's lectin-like properties mediate this binding.
  • To assess the impact of IL-2 binding on host immune responses to C. albicans.

Main Methods:

  • Incubation of heat-killed C. albicans with IL-2.
  • Assay of CTLL20 cell proliferation in response to IL-2 treated fungi.
  • Inhibition studies using soluble mannan.
  • Assessment of IL-2 binding using radiolabeled IL-2 and inhibition assays.
  • Evaluation of lymphoproliferative responses of human peripheral blood mononuclear cells.

Main Results:

  • IL-2 binding to C. albicans was confirmed.
  • Soluble mannan inhibited IL-2 binding by approximately 60%, indicating a role for lectin-like interactions.
  • IL-2 pre-incubation with C. albicans enhanced CTLL20 proliferation and augmented human mononuclear cell responses.
  • IL-2 binding to C. albicans was reversible.
  • No high-affinity IL-2 receptors were detected on C. albicans.

Conclusions:

  • IL-2 can bind to Candida albicans in vitro, partly due to its lectin-like properties.
  • This binding influences the host's immune response to C. albicans.
  • Further in vivo studies are needed to determine the clinical relevance of IL-2-fungal interactions.